Lancet

Article	Citations
Anatomy teaching, dissection, and dignity of the dead	10055
“I am disabled, it doesn’t mean I have no dignity”	3645
Antibiotic treatment duration for bacteraemic pneumonia	2331
Moderna stalls on African vaccine manufacturing plans	2297
Tonsillectomy for recurrent tonsillitis: the NATTINA trial	2055
Imagining alternative paths for WHO 75 years in	1545
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – Authors' reply	1304
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial	1258
Ophira Ginsburg: educating and empowering women with cancer	1216
US plan to shield science from “inappropriate influence”	1186
Anna Gilmore: confronting the commercial determinants of health	1160
Can COVID-19 help accelerate and transform the diagnostics agenda?	1157
Anthony Bryceson	1153
A high prostatic-specific antigen with a large pelvic mass indicates a prostatic cystadenocarcinoma	1109
床前孝子	1106
Annabel Sowemimo: countering inequities in health care	1086
Nigeria: health as a political prerequisite	1077
A fair day's wage for a fair day's work	1033
Sexual abuse and exploitation at WHO: an erosion of trust	1029
Immediate versus delayed sequential bilateral cataract surgery	1010
Cardiovascular safety of febuxostat	970
Health at stake in Kenya elections	927
Unclear conclusions on SARS-CoV-2 elimination versus mitigation	895
Remote haemodynamic monitoring in patients with heart failure – Authors' reply	871
An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial	869

Jenna Lester: advancing diversity in dermatology	863
Interferon shrinks spleen in pregnant patient with myeloproliferative neoplasm	816
Nafis Sadik	798
Offline: Changing the argument for health	769
Perilous two-tier COVID-19 global vaccine roll-out	767
Visa bureaucracy causing GPs to leave the UK	750
Prominent skin folds of the scalp provide a superficial clue in acromegaly	748
Changing gloves and switching instruments to decrease surgical site infection in abdominal surgery	707
Tackling heroin use in Mozambique	691
Associations between parental smoking and teenage alcohol and drug use in the Growing Up in Ireland cohort study: a longitudinal observational study	668
The acknowledgment of death	655
Protecting children from racism: urgent health system actions	640
Establishing equitable partnerships between the Global North and Global South	639
Visualising facial distortions in prosopometamorphopsia	636
Miriam Mutebi: transforming breast cancer care in Africa	633
Human rights considerations are key when choosing a conference location	605
Donald Bernard Longmore	601
Interpreting COVID-19 data from China: a call for caution	596
Human rights and health: a story of justice, hope, and resilience	589
Pandemics and the tourism industry: who is in control?	584
Does TRIANGLE take down transplantation in mantle cell lymphoma?	565
Characteristics of yoga providers and their sessions and students in the UK: a cross-sectional survey	564
Knowledge and attitudes towards organ donation among students at An-Najah National University: a cross-sectional study	553
Hypochondria, the ghost at medicine's feast	552
Calvarium indentations in multiple myeloma and CAR T-cell therapy	545
Department of Error	536
Department of Error	533
Department of Error	504
Department of Error	503
Department of Error	500
Department of Error	492
May Edward Chinn: pioneer of early cancer detection	481
WHO EMRO's initiative on economic sanctions: delayed but promising	475
Ronald Duncan Bradley	473
High-dose dual-antibiotic loaded bone cement in patients undergoing hemiarthroplasty	446
On the quantification of military violence in Gaza	443
Hypertrophic cardiomyopathy secondary to hydroxychloroquine toxicity in a patient with rheumatoid arthritis	442
Offline: What have we done to medical students?	441
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial – Authors' reply	441
Considerations for the CHH–Lancet Commission on Health, Conflict, and Forced Displacement	436
Israel border closure denying health care to Gazans	423
Gaining MOMENTUM against anaemic myelofibrosis	421
Nigeria's National Mental Health Act 2021: any challenges ahead?	419
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?	419
Increasing humanitarian concerns for 2023	416
How can engagement with political science and international relations for health be improved?	415
Department of Error	413
TRiP(cast) score and thrombosis risk for lower limb immobilisation – Authors' reply	409
Natural or artificial menstrual cycle for frozen embryo transfer	405
Cervical cancers avoided by HPV immunisation	405

Sackler money to go towards reducing overdose deaths	403
Offline: “I have no place to go”	402
Lower respiratory tract infections in early childhood	397
Routine immunisations: reversing the decline	394
Political courage needed to prevent the next pandemic	390
Lowitja O'Donoghue	390
Hearing intervention and cognitive decline: the ACHIEVE trial	390
CoronaVac efficacy data from Turkey – Authors' reply	388
Thinking outside of the tin box	388
Primary health-care practices for deaf children should include early incorporation of a signed language	381
Beverly Malone: valuing diversity in nursing	380
Treatment of vulnerable atherosclerotic plaques: the PREVENT trial	377
Physicians in the digital age	375
Retraction: The first tissue-engineered airway transplantation: 5-year follow-up results	370
Threat level in the Gaza Strip: fatalities per 1000 person-years	368
The Peer Education Project to improve mental health literacy in secondary school students in England: a qualitative realist evaluation	364
Omicron: fewer adverse outcomes come with new dangers	362
South Korean doctors threaten mass resignation	357
Morphine for Gaza? Limits of care during genocidal violence	354
To keep health as a unifying force, we must put resources into tackling health misinformation and disinformation	353
Reaching net zero carbon emissions in health systems	351
Racial inequities in homicide rates: Black women in the USA	345
A new era for Africa CDC	345
Tom Beauchamp	343
A taste of your own medicine: the experience of a transplant	338
Something good enough	337
Understanding the potential and pitfalls of digital phenotypes to measure population mental health and wellbeing	335
The road ahead for immediate kangaroo mother care in resource-constrained health systems	335
Moving past the COVID-19 emergency in the USA	328
Pembrolizumab for locally advanced cervical cancer	326
Primary health care on the ballot in Australian election	324
Australia to introduce sweeping e-cigarette regulations	324
Iscalimab 600 mg: justified or excessive? – Authors' reply	324
Mirtazapine for agitation in dementia: moving forward	323
Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine	320
Implementation of adaptation to climate change in public health in Europe: qualitative thematic analysis	320
Sanctions and the right to health in post-Assad Syria	320
The injustice of tuberculosis	318
Atosiban and managing women in preterm labour	314
Improving children's lives—the case for universality	313
Prioritising maternal health must include care before pregnancy	313
Merrill Singer	312
Haemophilia	310
Offline: Political declarations—clichés and lies	307
Can the FDA fulfil its mission with a smaller workforce?	305
IMbrave050: the first step towards adjuvant therapy in hepatocellular carcinoma	303
Use the remaining carbon budget wisely for health equity and climate justice	298
“I'm losing faith in everything”: a qualitative study to understand barriers to accessing suitable mental health support for children and young people in Wales	291
Neglected tropical diseases: ending the neglect of populations	288
Protein provision during critical illness	288
CAR T-cell perspectives in lupus – Authors' reply	284
A decolonised Commission agenda: the missing ingredients	283
The 2024 Lasker Awards	282
Fluid retention and heart failure in the PRECISION trial – Authors' reply	280
Pivotal points in the science of dementia risk reduction	278
Preventing cancer: the only way forward	278
Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review	277
Türkiye rocked by newborn care scandal	276
Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts	273
Brazil to start widespread dengue vaccinations	273
“It's not about us anymore”: after the Le Scouarnec case	270
Realising transformative change in adolescent health and wellbeing: a second Lancet Commission	270
Department of Error	269
Resurgence of cholera amidst ongoing war in Sudan	269
A new drug for rare diseases: pozelimab for CHAPLE disease	268
Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial	268
From innovation to impact in cardiovascular disease	268
Population health outcomes in Nigeria compared with other west African countries, 1998–2019: a systematic analysis for the Global Burden of Disease Study	267
Malaria vaccines: a test for global health	266
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi	264
From disappointment to despair: USAID cuts to Myanmar's HIV services	259
Key questions regarding the SYMPLICITY HTN-3 trial	259
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial	252
Mortality during migration through the Darién Gap in Panama in 2018–22	250
A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance	250
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study	247
Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use	246
HPV vaccination and cervical cancer screening	246
Considerations in boosting COVID-19 vaccine immune responses	246
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial	246

Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study	244
Strikes	242
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China	242
End compulsory drug treatment in the Asia-Pacific region	241
Mpox: the need for a coordinated international response	239
Regional action needed to halt antimalarial drug resistance in Africa	238
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis	238
COVID-19 mRNA vaccination and myocarditis or pericarditis	237
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial	237
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial	237
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials	236
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial	236
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised control	235
Department of Error	235
Legal accountability for climate change	234
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind	233
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Bur	233
Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlle	233
Report of the Lancet Commission on the Value of Death: bringing death back into life	228
Health and development from preconception to 20 years of age and human capital	228
The health dimensions of violence in Palestine: a call to prevent genocide	228
Childhood epilepsy	228
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)	227
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, random	227
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches	226
An age of uncertainty: mental health in young people	226
Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes	226
Delayed immune tolerance through donor haematopoietic stem cell infusion 14 months after kidney transplantation	226
The pathogenesis of Parkinson's disease	225
Theranos and the scientific community: at the bleeding edge	223
Eugene John Gangarosa	222
Lower taxes or greater health equity	221
The Lancet's enduring legacy: speaking truth to power	220
Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial	220
Monica Peek: addressing diabetes health disparities	219
Louis Pasteur's public engagement	219
A story of sisterhood	218
Marceline Tutu van Furth: inspiring future medical leaders	217
Progress in neonate safety	216
Ghost cells are the spectre of fetal-maternal haemorrhage	215
Raj Panjabi: bringing a global outlook to the US pandemic response	214
CD3xCD20 bispecific T-cell redirectors for relapsed or refractory B-cell lymphoma	214
Accelerating progress towards gender equity in health and science	213
Science in Iran: a victim of political turmoil	213
Misclassification bias in estimating clinical severity of SARS-CoV-2 variants	212
Diagnosing acute intestinal graft-versus-host disease by a non-invasive method: transabdominal ultrasonography and colour doppler imaging	209
Optimising the health-care experiences of babies, children, and young people	209
Conservative treatment of perforated diverticulitis: following the latest guidelines pays dividends	209
Error in NHS England's BMI calculator and daily calorie recommendations	207
Gender inclusivity in India's National Family Health Survey	206
Peter Waiswa: building better health systems in Africa and beyond	206
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy	205
Academic health sciences	205
Where are the children and adolescents?	203
The impact of the 2023 earthquakes on the Afghan health-care system	203
Documenting compassion and teamwork in maternity care	202
Auschwitz	199
Rob Moodie: a radical voice in public health	197
Warnings over the future of UK medical research	197
Obligations in a global health emergency	196
Shakuntala Thilsted: shifting our approach to food systems	196
The importance of empathy – Author's reply	194
Mechanical circulatory support for cardiogenic shock	193
The USA and the plight of children in a humanitarian crisis	193
Clopidogrel use in chronic coronary syndrome: a fragile lifelong choice	193
Responding to responsive behaviour in Alzheimer's disease – Author's reply	191
Time to fast-track interventions to road traffic crises in Iran	191
New EU Health Commissioner appointed amid controversy	191
Beyond COVID-19: scaling up and sustaining mobile health in Africa	190
Androgen deprivation therapy combined with postoperative radiotherapy for prostate cancer management	189
Should alcohol carry cancer warning labels?	188
Can we turn the tide on NCDs in 2025?	186
Accelerating domestic investments to end AIDS in Africa	185
Breastfeeding and the role of the commercial milk formula industry – Authors' reply	185
Opening the door to widespread iPSC-derived regenerative therapy for corneal epithelial opacity	185
The impact of war on the environment and health: implications for readiness, response, and recovery in Ukraine	181
Host-targeting oral antiviral drugs to prevent pandemics	180
Developing a vaccine against Marburg virus disease	179
USA–China tariffs on pharmaceuticals affect global health equity	179
“Even worse than fentanyls”: nitazenes in the USA	178
An urgent case for measles vaccination in Gaza	178
Protecting the blood donor: ferritin-based intervals to improve donor health	177
US Surgeon General: loneliness is a public health crisis	176
Vesicular monoamine transport inhibitors: current uses and future directions	176
Timing of cardiac surgery and anticoagulants after acute ischaemic stroke	175
The evolving landscape of pulmonary arterial hypertension clinical trials	174
Infectious diseases in 2025: a year for courage and conviction	174
Matching actions to needs: shifting policy responses to the changing health needs of Chinese children and adolescents	174
Realigning the physical activity research agenda for population health, equity, and wellbeing	174
Kangaroo mother care before stabilisation: the OMWaNA trial	173
One Health: a call for ecological equity	173
The Health Index: a framework to guide health-driven prosperity	172
Unanswered questions from the IRONMAN trial	171
Optimal usage of antibacterial sutures for wound closure in clinical trials addressing SSI – Authors' response	171
Libby Sallnow: the gentle disruptor	171